AstraZeneca made $10 billion offer for obesity drugmaker Rhythm Pharmaceuticals
AstraZeneca made a $10 billion takeover offer for Rhythm Pharmaceuticals, which specializes in treatments for metabolic conditions and severe obesity, according to sources familiar with the matter.
